Adiposity and skeletal muscle mass have been shown to be prognostic for mortality in several cancers. In a recent study, CT imaging at diagnosis was used to determine whether components of body composition were associated with survival in men with advanced prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Xu, M. C. et al. Obesity is associated with longer survival independent of sarcopenia and myosteatosis in metastatic and/or castrate-resistant prostate cancer. J. Urol. https://doi.org/10.1097/ju.0000000000001428 (2020).
Cespedes Feliciano, E. M. et al. Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients. J. Cachexia Sarcopenia Muscle 11, 1258–1269 (2020).
Lee, D. H. & Giovannucci, E. L. The obesity paradox in cancer: epidemiologic insights and perspectives. Curr. Nutr. Rep. 8, 175–181 (2019).
Toren, P. & Venkateswaran, V. Periprostatic adipose tissue and prostate cancer progression: new insights into the tumor microenvironment. Clin. Genitourin. Cancer 12, 21–26 (2013).
Cushen, S. J. et al. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel. Clin. Nutr. ESPEN 13, e39–e45 (2016).
Wu, W. et al. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS ONE 10, e0122047 (2015).
Brown, J. C. et al. The association of abdominal adiposity with mortality in patients with stage I-III colorectal cancer. J. Natl Cancer Inst. 112, 377–383 (2020).
Allott, E. H. et al. Racial differences in adipose tissue distribution and risk of aggressive prostate cancer among men undergoing radiotherapy. Cancer Epidemiol. Biomarkers Prev. 23, 2404–2412 (2014).
Baracos, V. E. & Arribas, L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann. Oncol. 29, ii1–ii9 (2018).
Daly, L. E., Prado, C. M. & Ryan, A. M. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes. Proc. Nutr. Soc. 77, 135–151 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests
Rights and permissions
About this article
Cite this article
Csizmadi, I., Aronson, W.J. Is body composition linked to prostate cancer survival?. Nat Rev Urol 18, 135–136 (2021). https://doi.org/10.1038/s41585-021-00427-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-021-00427-7